Premarket Biotech Digest: Arrowhead's Potential, KaloBios Delisting, BiondVax Patent

Home › Premarket Biotech Digest: Arrowhead's Potential, KaloBios Delisting, BiondVax Patent

But ARWR remains down sharply for the year. Year-to-date, ARWR is still down nearly 16%.

19.05	IT Cosmetics and Kenvue Launch New Products
19.05	Virgin Trains targets West Coast in return to rail
19.05	Cashing In On The Stache
19.05	Dr. Squatch Launches Bronco Bricc
19.05	Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05	Eastern North Pacific Tropical Weather Outlook
19.05	Atlantic Tropical Weather Outlook
19.05	Eastern North Pacific Tropical Weather Outlook
More »

je.st